Log in to save to my catalogue

Geranylgeraniol Application in Human Osteoblasts and Osteoclasts for Reversal of the Effect of Bisph...

Geranylgeraniol Application in Human Osteoblasts and Osteoclasts for Reversal of the Effect of Bisph...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_00e3b3cf3fbf4f1cb584d624f1e1c79d

Geranylgeraniol Application in Human Osteoblasts and Osteoclasts for Reversal of the Effect of Bisphosphonates

About this item

Full title

Geranylgeraniol Application in Human Osteoblasts and Osteoclasts for Reversal of the Effect of Bisphosphonates

Publisher

Switzerland: MDPI AG

Journal title

Life (Basel, Switzerland), 2023-06, Vol.13 (6), p.1353

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Nitrogen-containing bisphosphonates lead to the depletion of geranylgeranyl pyrophosphate involved in the mevalonate pathway. The effect of geranylgeraniol (GGOH) on human osteoblast and osteoclast activities suppressed by zoledronate was investigated in this study. The effect of GGOH on human osteoblasts and osteoclasts subjected to treatment with...

Alternative Titles

Full title

Geranylgeraniol Application in Human Osteoblasts and Osteoclasts for Reversal of the Effect of Bisphosphonates

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_00e3b3cf3fbf4f1cb584d624f1e1c79d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_00e3b3cf3fbf4f1cb584d624f1e1c79d

Other Identifiers

ISSN

2075-1729

E-ISSN

2075-1729

DOI

10.3390/life13061353

How to access this item